Literature DB >> 32875417

P338: summarizing measures of proficiency in transanal total mesorectal excision-a systematic review.

Alen Antoun1, Johnny Chau1, Nourah Alsharqawi1, Pepa Kaneva1, Liane S Feldman1, Carmen L Mueller1, Lawrence Lee2.   

Abstract

INTRODUCTION: Transanal total mesorectal excision (TaTME) is technically challenging even for experienced colorectal surgeons and there may be a higher risk of complications during learning. Determining when a surgeon is ready to safely perform this technique independently remains a matter of debate. Therefore, the objective of this study was to systematically summarize the available evidence regarding measures of proficiency in TaTME for rectal adenocarcinoma.
METHODS: A systematic search of MEDLINE, Embase, PubMed Epub records, Biosis previews, Scopus, and Cochrane Library databases was performed according to PRISMA guidelines. All English and French language studies published between 2010 and 2018 that described proficiency metrics for TaTME were included. Study heterogeneity precluded meta-analysis, and therefore qualitative synthesis was performed. The primary outcomes were the methodology and measures used to define proficiency, and the number of cases needed to achieve proficiency.
RESULTS: Of 994 citations, five studies met inclusion criteria. Of these, only two used objective measures to define proficiency. These studies evaluated patient outcomes and defined proficiency through cumulative sum (CUSUM) analysis of the primary outcome(s): post-operative complications and TME quality. Two studies reported expert consensus to establish recommendations using a combination of electronic survey distributed to colorectal surgeons and consensus conferences with TaTME experts from 7 to 8 different countries. One study defined the learning phase as 16 months of TaTME practice, or the first 27 cases. Stated case volumes needed to achieve proficiency varied widely. Studies using objective outcome measures reported threshold volumes of 40 and 51 cases, respectively, while expert consensus studies recommended needing 6-30 procedures.
CONCLUSIONS: Significant heterogeneity exists regarding the determination of proficiency benchmarks for TaTME. Expert consensus documents recommend lower case numbers to obtain proficiency than those defined by objective measures, suggesting greater experience may be required than generally thought.

Entities:  

Keywords:  Colorectal surgery; Learning curve; Proficiency; Skill acquisition; Surgical education; Transanal total mesorectal excision

Mesh:

Year:  2020        PMID: 32875417     DOI: 10.1007/s00464-020-07935-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  40 in total

1.  The use of the Cusum technique in the assessment of trainee competence in new procedures.

Authors:  S Bolsin; M Colson
Journal:  Int J Qual Health Care       Date:  2000-10       Impact factor: 2.038

2.  Learning curve for laparoscopic major hepatectomy.

Authors:  T Nomi; D Fuks; Y Kawaguchi; F Mal; Y Nakajima; B Gayet
Journal:  Br J Surg       Date:  2015-04-15       Impact factor: 6.939

3.  Transanal Total Mesorectal Excision: International Registry Results of the First 720 Cases.

Authors:  Marta Penna; Roel Hompes; Steve Arnold; Greg Wynn; Ralph Austin; Janindra Warusavitarne; Brendan Moran; George B Hanna; Neil J Mortensen; Paris P Tekkis
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

4.  Transanal resection: a novel approach.

Authors:  S Van Loo; S Vanderputte
Journal:  Acta Chir Belg       Date:  2013 May-Jun       Impact factor: 1.090

Review 5.  Transanal total mesorectal excision: technical aspects of approaching the mesorectal plane from below.

Authors:  Joep Knol; Sami A Chadi
Journal:  Minim Invasive Ther Allied Technol       Date:  2016-10       Impact factor: 2.442

6.  An assessment of an Australasian pathway for the introduction of transanal total mesorectal excision (taTME).

Authors:  S C Abbott; A R L Stevenson; S W Bell; D Clark; A Merrie; J Hayes; S Ganesh; A G Heriot; S K Warrier
Journal:  Colorectal Dis       Date:  2018-01       Impact factor: 3.788

7.  NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance.

Authors:  Patricia Sylla; David W Rattner; Salvadora Delgado; Antonio M Lacy
Journal:  Surg Endosc       Date:  2010-02-26       Impact factor: 4.584

8.  Transanal total mesorectal excision for rectal cancer has been suspended in Norway.

Authors:  H H Wasmuth; A E Faerden; T Å Myklebust; F Pfeffer; S Norderval; R Riis; O C Olsen; J R Lambrecht; H Kørner; S G Larsen; H M Forsmo; O Baekkelund; S Lavik; J C Knapp; O Sjo; G Rashid
Journal:  Br J Surg       Date:  2019-12-05       Impact factor: 6.939

9.  Initiation of a Transanal Total Mesorectal Excision Program at an Academic Training Program: Evaluating Patient Safety and Quality Outcomes.

Authors:  Justin A Maykel; Uma R Phatak; Pasithorn A Suwanabol; Andrew T Schlussel; Jennifer S Davids; Paul R Sturrock; Karim Alavi
Journal:  Dis Colon Rectum       Date:  2017-12       Impact factor: 4.585

10.  Uptake of Transanal Total Mesorectal Excision in North America: Initial Assessment of a Structured Training Program and the Experience of Delegate Surgeons.

Authors:  Sam B Atallah; Arielle C DuBose; John P Burke; George Nassif; Teresa deBeche-Adams; Taylor Frering; Matthew R Albert; John R T Monson
Journal:  Dis Colon Rectum       Date:  2017-10       Impact factor: 4.585

View more
  2 in total

1.  Development and evaluation of a virtual knowledge assessment tool for transanal total mesorectal excision.

Authors:  Hamzeh Naghawi; Johnny Chau; Amin Madani; Pepa Kaneva; John Monson; Carmen Mueller; Lawrence Lee
Journal:  Tech Coloproctol       Date:  2022-05-03       Impact factor: 3.699

2.  The Learning Curve of Computer-Assisted Free Flap Jaw Reconstruction Surgery Using 3D-Printed Patient-Specific Plates: A Cumulative Sum Analysis.

Authors:  Wang-Yong Zhu; Wing Shan Choi; May Chun Mei Wong; Jingya Jane Pu; Wei-Fa Yang; Yu-Xiong Su
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.